What type and quantity of clinical evidence is required by payers in formulating positive coverage policies for products and procedures?

If you don’t have a clear answer, you’re not alone. As a board member of the Alliance of Wound Care Stakeholders, I invite you to our upcoming Wound Care Evidence Summit – a unique opportunity to solve this and other evidence/coverage challenges together with government and commercial payers, Federal policymakers and regulators, researchers, medical societies, and manufacturers.

Click here to grab your spot today.